Astellas’s Venture Arm Is Focused On Flexibility But Avoiding Hype

Greenshoots
Hardiman is seeing 'green shoots of recovery' in the biopharma market • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from VC Playbook

More from Growth